Medicinal cannabis trial begins for Australian veterans with PTSD
An Australian-first trial using medicinal cannabis to treat returned servicemen and women suffering from post-traumatic stress disorder (PTSD) has been launched today that targets defence personnel who have not had a response to conventional treatments.
Key points:
Researchers are seeking 300 people to take part in the national trial, which has attracted attention from the veteran community
The Australian Defence Force reports about 8.3 per cent of its members have experienced PTSD in the past 12 months
The ADF says the rate among males is almost double the general community